Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2015 | Volume: 11 | Issue: 1 | Page No.: 10-18
DOI: 10.3923/ijp.2015.10.18
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Triptolide Protects Dopaminergic Neurons from 6-OHDA Lesion in a Rat Model of Parkinson’s Disease
Wenjing Zhang, Haiting An, Feilong Zhang, Lin Dong, Qi Wang, Ruijun Su, Yanjing Qian and Xiaoli Gong

Abstract:
Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic (DA) neurons in the Substantia Nigra pars Compacta (SNc). There is no satisfactory therapeutic strategy for PD as yet. Here, triptolide (T10), a major active compound extracted from Tripterygium wilfordii Hook. f. (TWHF), a Traditional Chinese Medicine (TCM) used to treat autoimmune diseases, was found to significantly diminish the number of abnormal rotations induced by apomorphine in 6-hydroxydopamine (6-OHDA)-lesioned PD rat model and protected DA neurons in SNc from 6-OHDA toxicity. Triptolide treatment was found to significantly suppress the activation of microglia and reduce the levels of oxidation products of proteins and lipids in the striatonigral systems of the PD model rats. Results suggest that triptolide might be a suitable lead compound in drug discovery for PD therapy.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Wenjing Zhang, Haiting An, Feilong Zhang, Lin Dong, Qi Wang, Ruijun Su, Yanjing Qian and Xiaoli Gong, 2015. Triptolide Protects Dopaminergic Neurons from 6-OHDA Lesion in a Rat Model of Parkinson’s Disease. International Journal of Pharmacology, 11: 10-18.

DOI: 10.3923/ijp.2015.10.18

URL: https://scialert.net/abstract/?doi=ijp.2015.10.18

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom